• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: Fitbit escapes Jawbone’s trade secret theft claims

UPDATE: Fitbit escapes Jawbone’s trade secret theft claims

August 24, 2016 By Brad Perriello

Jawbone, Fitbit

Updated with comment from Jawbone.

Fitbit (NYSE:FIT) yesterday beat rival Jawbone‘s accusations that it stole trade secrets for its wearable fitness tracking device when a judge for the U.S. International Trade Commission ruled that there were no violations of the Tariff Act because “no party has been shown to have misappropriated any trade secret.”

The decision by Judge Dee Lord spikes Jawbone’s attempt to block imports of the Fitbit devices, part of its ITC complaint alleging that Fitbit infringes 6 of its patents and poached workers who brought confidential data with them when they jumped ship – including plans, supply chains and technical details.

But Jawbone withdrew 2 of the patents and Lord ruled the remaining 4 invalid ahead of a May trial on the trade secret accusations.

“From the outset of this litigation, we have maintained that Jawbone’s allegations were utterly without merit and nothing more than a desperate attempt by Jawbone to disrupt Fitbit’s momentum to compensate for their own lack of success in the market,” Fitbit CEO James Park said in prepared remarks.

Jawbone said it plans to appeal the decision and will pursue a larger trade secret case against Fitbit in the coming months.

“We intend to seek review of today’s ruling before the full Commission.  The case in the ITC involved a very small subset of Jawbone’s trade secrets asserted against Flextronics and Fitbit because of the limited jurisdiction of the ITC.  Jawbone is continuing to pursue its much broader trade secret case against Fitbit, which is headed to a jury trial in California state court.   The California court already has granted a preliminary injunction and rejected Fitbit’s efforts to dismiss the case.  Jawbone is confident it will prevail when the full scope of its claims is heard by the jury,” a jawbone representative wrote to MassDevice.com

The news sent FIT shares up 2.8% today in pre-market trading, to their opening price of $15.30 apiece. The stock gained 2.2% in early trading, rising to $15.20 per share.

Fitbit’s win comes after a loss last month in an ITC complaint it leveled against Jawbone, in which ITC Judge Thomas Pender invalidated a trio of Fitbit patents; Fitbit has asked the full commission to review that decision.

The companies are also sparring in state and federal court; Jawbone led with a trade secret violations case in California state court that’s still pending, as are patent infringement proceedings in federal court.

(Material from Reuters was used in this report).

Filed Under: Digital Health, Legal News, Patent Infringement Tagged With: Fitbit, International Trade Commission (ITC), Jawbone

More recent news

  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy